Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Asset Writedowns and Impairment (2016 - 2025)

Lexaria Bioscience's Asset Writedowns and Impairment history spans 8 years, with the latest figure at $213824.0 for Q3 2025.

  • Quarterly results put Asset Writedowns and Impairment at $213824.0 for Q3 2025, up 527.0% from a year ago — trailing twelve months through Aug 2025 was $163748.0 (up 427.0% YoY), and the annual figure for FY2025 was $247364.0, up 3087.68%.
  • Asset Writedowns and Impairment for Q3 2025 was $213824.0 at Lexaria Bioscience, up from -$50076.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $213824.0 in Q3 2025 to a low of -$50076.0 in Q3 2024.
  • The 3-year median for Asset Writedowns and Impairment is $24367.5 (2021), against an average of $53120.8.
  • Peak annual rise in Asset Writedowns and Impairment hit 527.0% in 2025, while the deepest fall reached 527.0% in 2025.
  • Year by year, Asset Writedowns and Impairment stood at $48018.0 in 2021, then crashed by 204.29% to -$50076.0 in 2024, then skyrocketed by 527.0% to $213824.0 in 2025.
  • According to Business Quant data, Asset Writedowns and Impairment over the past three periods came in at $213824.0, -$50076.0, and $48018.0 for Q3 2025, Q3 2024, and Q3 2021 respectively.